| Literature DB >> 32445005 |
Sheri L Towe1, Christina S Meade1, Christine C Cloak2, Ryan P Bell1, Julian Baptiste2, Linda Chang3,4,5.
Abstract
Globally, cannabis is the most commonly used illicit drug, with disproportionately high use among persons with HIV. Despite advances in HIV care, nearly half of persons living with HIV continue to experience neurocognitive deficits or impairments that may have negative impacts on their daily function. Chronic cannabis use may play a role in the development or exacerbation of these impairments. Here we present a review summarizing existing research detailing the effect of cannabis use associated with the neuropathogenesis of HIV. We examine evidence for possible additive or synergistic effects of HIV infection and cannabis use on neuroHIV in both the preclinical and adult human literatures, including in vitro studies, animal models, clinical neuroimaging research, and studies examining the cognitive effects of cannabis. We discuss the limitations of existing research, including methodological challenges involved with clinical research with human subjects. We identify gaps in the field and propose critical research questions to advance our understanding of how cannabis use affects neuroHIV. Graphical Abstract.Entities:
Keywords: Cannabis; Endocannabinoid system; HIV; Neuropathogenesis
Year: 2020 PMID: 32445005 PMCID: PMC7680275 DOI: 10.1007/s11481-020-09921-y
Source DB: PubMed Journal: J Neuroimmune Pharmacol ISSN: 1557-1890 Impact factor: 4.147